Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Activated protein C resistance and lipoprotein (a) in young adults with branch retinal vein occlusion

Activated protein C resistance and lipoprotein (a) in young adults with branch retinal vein... We investigated the effects of activated protein C resistance (APCR), Factor V Leiden (FVL) mutation, and high lipoprotein (a) levels in 32 young patients with branch retinal vein occlusion (BRVO) vs 30 controls. No difference between patients with BRVO and controls was found with regard to APCR, FVL mutation, or lipoprotein (a) levels. These factors do not seem important in the etiology of BRVO. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Ophthalmology Springer Journals

Activated protein C resistance and lipoprotein (a) in young adults with branch retinal vein occlusion

Download PDF
5 pages

Loading next page...
 
/lp/springer-journals/activated-protein-c-resistance-and-lipoprotein-a-in-young-adults-with-fCshsHJ0Pu
Publisher
Springer Journals
Copyright
Copyright © 2005 by ASCO
Subject
Medicine & Public Health; Ophthalmology
ISSN
1530-4086
eISSN
1558-9951
DOI
10.1385/AO:37:4:267
Publisher site
See Article on Publisher Site

Abstract

We investigated the effects of activated protein C resistance (APCR), Factor V Leiden (FVL) mutation, and high lipoprotein (a) levels in 32 young patients with branch retinal vein occlusion (BRVO) vs 30 controls. No difference between patients with BRVO and controls was found with regard to APCR, FVL mutation, or lipoprotein (a) levels. These factors do not seem important in the etiology of BRVO.

Journal

Annals of Ophthalmology – Springer Journals

Published: Apr 25, 2007

References

  • Pathophysiology and hemodynamics of branch retinal vein occlusion
    Christoffersen, NLB; Larsen, M
  • Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion
    Sperduto, RD; Hiller, R; Chew, E
  • Systemic diseases associated with various types of retinal vein occlusion
    Hayreh, SS; Zimmerman, B; McCarthy, MJ; Podhajsky, P
  • Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion
    Tekeli, O; Gürsel, E; Buyrgan, H
  • Thrombin-antithrombin III complex in acute retinal vein occlusion
    Hjima, H; Gohdo, T; Imai, M; Tsukahara, S
  • The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study
    Incorvaia, C; Parmeggiani, F; Costagliola, C
  • Hyperhomocyst(e)inemia, but not methylentetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion
    Weger, M; Stanger, O; Deutchmann, H
  • Lipemia retinalis associated with branch retinal vein occlusion
    Nagra, PK; Ho, AC; Dugan, JD
  • Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease
    Cahill, M; Karabatzaki, M; Meleady, R
  • Primary antiphospholipid syndrome presenting with a branch retinal artery occlusion in a 15-year-old boy
    Saxonhouse, MA; Bhatti, MT; Driebe, WT; Freeman, BE; Maria, BC
  • Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study
    Cobo-Soriano, R; Sanchez-Ramon, S; Aparicio, MJ
  • Clinical and laboratory evaluation of thrombophilia
    Perry, SL; Ortel, TL
  • Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G202 10A in adult Turkish patients with thrombosis
    Gürgey, A; Haznedaroglu, IC; Egesel, T
  • Risk factors in central retinal vein occlusion and activated protein C resistance
    Güven, D; Saymalp, N; Kalayet, D; Dündar, S; Hasripi, H
  • High prevalence of resistance to APC in young patients with retinal vein occlusion
    Kuhli, C; Hattenbach, LO; Scharrerl; Koch, F; Ohrloff, C
  • Retinal vascular occlusion and deficiencies in the protein C pathway
    Greiner, K; Hafner, G; Dick, B; Peetz, D; Prellwitz, W; Pfeiffer, N
  • Hematologic abnormalities associated with various types of retinal vein occlusion
    Hayreh, SS; Zimmerman, MB; Podhajsky, P
  • Familial thrombophilia and retinal vein occlusion
    Backhouse, O; Parapia, L; Mahomed, I; Lee, D
  • Screening for resistance to activated protein C and the mutant gene for factor V: Q506 in patients with central retinal vein occlusion
    Vine, AK; Samama, MM
  • Lipoprotein (a): a risk factor for retinal vascular occlusion
    Müller, HM; Diekstall, FF; Schmidt, E; Canzler, H; Demeler, U
  • Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk
    Lip, PL; Jones, AF; Lip, GY
  • Retinal vein occlusion and lipoprotein (a)
    Ribeaudeau-Saindelle, F; Glacet-Bernard, A; Lelong, F; Coscas, G; Soubrane, G
  • Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion
    Glueck, CJ; Bell, H; Vadlamani, LL